Volume 15 Issue 2
Aug.  2022
Turn off MathJax
Article Contents
YU Jiao-yang. Best opportunity for CRRT to treat infectious acute kidney injury[J]. Chinese Journal of General Practice, 2017, 15(2): 246-248. doi: 10.16766/j.cnki.issn.1674-4152.2017.02.019
Citation: YU Jiao-yang. Best opportunity for CRRT to treat infectious acute kidney injury[J]. Chinese Journal of General Practice, 2017, 15(2): 246-248. doi: 10.16766/j.cnki.issn.1674-4152.2017.02.019

Best opportunity for CRRT to treat infectious acute kidney injury

doi: 10.16766/j.cnki.issn.1674-4152.2017.02.019
  • Received Date: 2016-05-11
    Available Online: 2022-08-05
  • Objective To discuss the best opportunity of using continuous renal replacement therapy (CRRT) for the treatment of infective acute kidney injury,and provide certain clinical data for standard treatment in patients with acute kidney injury. Methods From January,2013 to December,2015,120 patients with acute kidney injury having CRRT treatment in our hospital were chosen and divided intoⅠ,Ⅱ and Ⅲ period group by KDIGO criteria.The hospital mortality and renal function recovery rate were compared among the three groups.The APACHE Ⅱ score,SOFA score,oxygenation index,mean arterial pressure,levels of serum creatinine and blood urea nitrogen,cases using vascular active drug were compared before and 48 h after CRRT treatment in each group. Results The mortality and renal function complete recovery rate among the three groups had statistically significant differences (χ2=10.394 and 22.200,all P<0.05).The mortality rate in phase Ⅲ group was significantly higher than that in phase Ⅰ and phase Ⅱ group,while the renal function fully recover rate in phase Ⅲ group was significantly lower than that in phase I and phase Ⅱ group,the differences was statistically significant (χ2 ≥ 6.545,all P<0.017).The serum creatinine,blood urea nitrogen,oxygenation index,mean arterial pressure,APACHE Ⅱ score and SOFA score in phase Ⅰ and phase Ⅱ groups were improved significantly after the treatment (t ≥ 4.09,all P<0.05),but not in phase Ⅲ group (t ≤ 1.61,all P>0.05). Conclusion CRRT treatment can obviously improve the prognosis of period Ⅰ and Ⅱ patients,but not of period Ⅲ patients (KDIGO standard),the best opportunity for CRRT should be paid more attention in practice.

     

  • loading
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (154) PDF downloads(1) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return